What we’re reading: Treatment is prevention, TB is a priority, welcome words and more

By on .

“This means that people who take ART daily as prescribed . . . and achieve and maintain an undetectable viral load have effectively no risk of sexually transmitting the virus to an HIV-negative partner . . .” With these words the U.S. Centers for Disease Control and Prevention effectively put on the record a truth […]

MAP-IT tool helps make decisions on childhood TB interventions investments

By on .

The following is a guest post by Olivia Burrus, Allyson Drew, Emily MacGuire  of RTI International and Irina Usherenko of TB Alliance Childhood TB is a major issue, infecting up to one million children each year. The good news is that there are several effective diagnostic, treatment, and prevention strategies that can have a major […]

PrEP presents questions for HIV prevention researchers, survey seeks answers

By on .

The trial to determine the effectiveness of a vaccine against HIV that was known as HVTN 505 was underway in 2010 when results from another, wholly unrelated trial presented a challenge. Those results, from the iPrEx trial, showed that an antiretroviral drug taken as pre-exposure prophylaxis — or PrEP — was effective in protecting uninfected […]

Study: Preventive infection-fighting drugs can cut deaths in people starting HIV treatment late

By on .

In the era of World Health Organization guidelines recommending immediate antiretroviral treatment for people with HIV before the disease progresses, the reality in sub-Saharan Africa remains that up to 25 percent of patients who show up at clinics show up with extremely advanced illness, and that about 10 percent of them die soon after starting […]

What we’re reading: Leahy on HIV funding, Global Gag Rule costs, and equalizing access to preferred medicines

By on .

While awaiting appropriations decisions that will establish the public health priorities and capacities for responding to infectious diseases at home and in countries around the world over the coming year, questions include how available moneys can be put to the most effective use. This week we’re reading about both policies and strategies that  make a […]

Who needs infectious disease docs? Everyone . . .

By on .

Journal supplement delves into the rewards and challenges of chasing bugs no one wants to catch . . . Of all the specialties a young physician can enter, one that offers a career of saving lives and protecting communities, supporting social justice and alleviating suffering, while following questions and finding answers across health systems, neighborhoods […]

WHO report highlights need for new TB drugs

By on .

 “An analysis of the antibacterial clinical development pipeline, including tuberculosis” finds development falling short especially for tuberculosis . . . Report finds second-line treatment regimens for TB already compromised, evidence of increasing transmission of multi, extensively drug-resistant TB, while lack of economic incentives continue to stall new tuberculosis drug development . . .     […]

State Department, PEPFAR release good news and a “strategy” short on details, definition

By on .

Names 13 countries for “particular focus” with aim for epidemic control by 2020 . . . Botswana, Côte d’Ivoire, Haiti, Kenya, Lesotho, Malawi, Namibia, Rwanda, Swaziland, Tanzania, Uganda, Zambia, Zimbabwe to be focus of efforts . . . Providing some clarification to proposals to shift the focus of the President’s Emergency Plan for AIDS Relief […]